AJCN Tufts Nutrition Symposium, Boston & Online Sept 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stabler, S. P
Right arrow Articles by Johnson, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stabler, S. P
Right arrow Articles by Johnson, M. A.
Agricola
Right arrow Articles by Stabler, S. P
Right arrow Articles by Johnson, M. A.
American Journal of Clinical Nutrition, Vol. 84, No. 6, 1422-1429, December 2006
© 2006 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

Elevated serum S-adenosylhomocysteine in cobalamin-deficient elderly and response to treatment1,2,3

Sally P Stabler1, Robert H Allen1, Evi T Dolce1 and Mary Ann Johnson1

1 From the Department of Medicine, University of Colorado Health Sciences Center, Denver, CO (RHA and SPS), and the Department of Foods and Nutrition, University of Georgia, Athens, GA (MAJ and ETD)

Background: S-Adenosylmethionine (SAM)–dependent methylation reactions produce S-adenosylhomocysteine (SAH), the precursor of homocysteine, which has been associated with adverse events when it is elevated.

Objective: We studied a cohort of elderly with a high prevalence of cobalamin deficiency to determine whether SAH, SAM, or their ratio was abnormal; whether they correlated with other markers of vitamin deficiency; and whether they changed with cobalamin therapy.

Design: A convenience sample of elderly attending nutrition centers was enrolled for baseline demographic, biochemical, and nutritional assessments. Methylmalonic acid (MMA), total homocysteine, and other metabolites were measured by using gas chromatography–mass spectrometry. Serum SAM and SAH were measured by using stable-isotope-dilution liquid chromatography–mass spectrometry. Subjects found to have elevated serum MMA were treated with oral cyanocobalamin tablets (1000 µg/d) for 3 mo. Subjects with normal MMA were randomly assigned to 1 of 3 dosage groups: 0, 25, or 100 µg cyanocobalamin/d.

Results: The 149 elderly subjects had a mean age of 76.3 y; 81% were female, and 30% were African American. Serum MMA concentrations were elevated in 30% and SAH concentrations were elevated in 64% of the cohort. Those with elevated MMA concentrations had higher SAH and SAM concentrations. High-dose oral cobalamin lowered SAH, MMA, and total homocysteine concentrations significantly, although subjects with creatinine concentrations >109 umol/L had higher posttreatment SAH than did those with lower creatinine.

Conclusions: Elevated serum SAH concentrations are common in elderly and are strongly influenced by both renal status and cobalamin deficiency. These elevated concentrations can be lowered with high-dose oral cobalamin therapy.

Key Words: Methylmalonic acid • vitamin B-12 • total homocysteine • folate • S-adenosylmethionine







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The American Society for Nutrition